MJBizDaily
Cannabis MSO Ascend prepares for uplisting to US exchange
Latest Posts
Altieri steps down as chief of marijuana advocacy group NORML
Erik Altieri, who has served as executive director of NORML since November 2016, announced his departure from the Washington DC-based marijuana advocacy organization.
News March 7Virginia cannabis advocates push for changes to approved delta-8 bill
The Virginia Cannabis Association (VCA) wants the state's recently passed delta-8 THC bill to be amended because it is too restrictive and could hurt the local hemp industry.
News March 7Nevada marijuana sales shrank 3.8% to $965.1M from mid-2021 to mid-2022
Nevada marijuana consumers spent $965.1 million on adult-use and medical cannabis between July 1, 2021, and June 30, 2022, a 3.8% decline from the previous-year period.
News March 7Canadian producers report 2,200 kilograms of lost or stolen cannabis since 2018
An increasing amount of cannabis grown by licensed Canadian producers has been lost or stolen over the past five years, new data shared with MJBizDaily shows.
News March 7Biden administration makes good on one marijuana-policy promise
In a move that could signal the Biden Administration's commitment to federally rescheduling of marijuana, the U.S. Department of Justice is now accepting applications for pardons from individuals convicted of or…
News March 6California launches $20M grant program to expand local retail cannabis programs
California regulators are rolling out a $20 million grant program to help incentivize dozens of counties and cities to establish or expand retail cannabis programs.
News March 6Missouri adult-use marijuana sales top $71.7 million in first month
Adult-use marijuana sales in Missouri hit the ground running, reaching $71.7 million in its first month.
News March 6Aurora Cannabis CEO’s ‘transformation’ of company offers lessons for rivals
Aurora Cannabis CEO Miguel Martin discusses his role in the "transformation" of the company from a money-losing venture to one on the upswing.
News March 6Bids stall to restrict high-THC products in Washington state
Efforts to cap the potency of cannabis products in Washington state and limit high-potency THC to the medical marijuana market appear to have failed.
News March 3












